期刊文献+

晚期卵巢恶性肿瘤的热化疗 被引量:3

Thermochemotherapy for Advanced Malignant Ovarian Tumor
在线阅读 下载PDF
导出
摘要 【目的】探讨热疗与化疗结合在卵巢恶性肿瘤治疗中的作用。【方法】采用热化疗治疗22例术后有残余肿块的卵巢恶性肿瘤患者(实验组),与同期12例常规化疗病人(对照组)进行比较。使用VHR-915MV热疗机,手术中将带有导管的探头置于肿块下,当温度达到41℃或较加温前上升3℃以上时继续保持40min。同时采用以顺铂为主的全身及腹腔双途径化疗,共计2~4疗程。【结果】2~3疗程后实验组完全缓解率(CR)45.4%,部分缓解率(PR)22.7%,有效率68.1%。对照组CR率83%,PR率25%,有效率33.3%,低于实验组。实验组有6例获得再次手术机会,其中2例术后病理证实达到临床及病理CR。该疗法无明显不良反应。【结论】热疗作一种辅助治疗与化疗有协同作用,可望提高晚期卵巢恶性肿瘤的治愈率。 To explore the therapeutic effects of chemotherapy combinig with hyperthermia on malignant ovarian tumors. A comparison of therapeutic effects between 22 patients carrying residual tumors treated with thermochemotherapy (study group)and 12 patients treated with routine chemotherapy alone(control group) was performed.Using UHR-915 MV thermotherapy machine effective heat could penetrate a depth of 12 cm.During operation a probe with catheter was put under the cancer mass.When temperature reached 41 or rose 3 above that before heating,40 min was maintained.At the same period cis-diaminodichloroplatinum(DDP)-based regimen used as systemic and intraperitoneal chemotherapy was added and totally 24 courses were given. After 23 courses of thermochemotherapy, the overall response rate was 682% with a complete remission rate (CR)of 45.4% and partial CR rate (PR) of 22.7%.The former two percentages were higher than 33.3% and 8.3% of the control group(its PR was 25%),respectively.Furthermore,6 patients in st udy group got the opportunity of second operation,clinical and pathological CR were obtained in 2 of them.Toxicity and side effects were not beyond tolerance. As a adjuvant method,hypP2erthermia combining with chemotherapy can result in synergism.Thermochemotherapy can improve the therapeutic effects for advanced malignant ovarian tumors and deserve further trial.
机构地区 湖南省肿瘤医院
出处 《湖南医学》 1999年第3期169-170,共2页 Hunan Medical Journal
关键词 卵巢肿瘤 药物疗法 热化疗 ovarian neoplasms cancer drug therapy hyperthermia,induced
  • 相关文献

同被引文献7

  • 1Kirmani S, Braly PS, Mcclay EF, et al. A comparison of intravenous versus intraperitoneal chemotherapy for the initial treatment of ovarian cancer. Gynecol Oncol, 1994,54 (3) :338-344.
  • 2Shapiro F, Schneider J, Markman M, et al. High-intensity intravenous cyclophosphamide and cisplatin, interim surgical debulking,and intraperitoneal cisplatin in advanced ovarian carcinoma:a pilot trial with ten-year follow-up.Gynecol oncol, 1997,67 (1) :39-45.
  • 3Cunliffe WJ, Sugarbaker PH. Gastrointestinal malignancy:rationale for adjuvant therapy using early postoperative intrapetoneal chemotherapy. Br J Surg, 1989,76(10):1082-1090.
  • 4Portilla AG, Sugarbaker PH, Chang D. Second look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer:analysis of prognostic features. World J Surg, 1999,23 (1) :23-29.
  • 5Hosftra LS, de Vries EGE, Mulder NH, et al.Intraperitoneal chemotherapy in ovarian cancer.Cancer Treat Rev,2000,20(3):133-143.
  • 6米村丰.癌腹膜播种的温热化学疗法与腹膜次全切除术[J].日本医学介绍,1998,19(11):488-489. 被引量:11
  • 7马建军,史彦芬,杨国平,王义善.化疗并高频透热治疗中晚期胃癌的临床研究[J].肿瘤,2001,21(2):130-131. 被引量:4

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部